Page last updated: 2024-08-23

lonidamine and Local Neoplasm Recurrence

lonidamine has been researched along with Local Neoplasm Recurrence in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrieu, JM; Banu, E; Carpentier, A; Celerier, D; Delattre, JY; Dutrillaux, B; Fauchon, F; Oudard, S; Poupon, MF1
Brunetti, I; Conte, PF; Dargenio, F; Fanucchi, A; Gadducci, A; Giannessi, PG; Muttini, MP1
Angelini, F; Ausili Cefaro, GP; Blengio, F; Cirulli, S; Cognetti, F; Colella, E; Giannarelli, D; Lo Russo, V; Merlano, M; Scasso, F1
Caputo, A; Carapella, CM; Cattani, F; Ciottoli, GB; Floridi, A; Iandolo, B; Paggi, MG; Raus, L; Riccio, A1

Trials

4 trial(s) available for lonidamine and Local Neoplasm Recurrence

ArticleYear
Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme.
    Journal of neuro-oncology, 2003, Volume: 63, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Diazepam; Female; Glioblastoma; Humans; Indazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Survival Rate

2003
Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Epirubicin; Female; Humans; Indazoles; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Salvage Therapy

1994
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Indazoles; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local

1994
The potential role of lonidamine (LND) in the treatment of malignant glioma. Phase II study.
    Journal of neuro-oncology, 1989, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Glioma; Humans; Indazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrazoles

1989